Ken-ichiro Kosai

2 Patents

• US123109982025

  Therapeutic Pharmaceutical Composition for Bone and Soft Tissue Tumors

  Surv Biopharma Inc.

  0 cites
• US118966352024

  Oncolytic Virus (oncolytic Immunotherapy) Capable of Effectively Treating Even Metastatic Cancer While Ensuring Safety, with Expression Control System Providing Optimal Expression Level of Mounted Immunogenic Gene

  KAGOSHIMA UNIVERSITY

  0 cites